Meteora Capital »

Esperion Therapeutics shares owned by Meteora Capital

Quarter-by-quarter ownership of Esperion Therapeutics shares owned by Meteora Capital from 13F filings

Historical chart of Meteora Capital investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Meteora Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Meteora Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.6M 4.6M 1.21

More positions owned by Meteora Capital

Spring Valley Acquisition Corp III Equity
Cantor Equity Partners I Equity (CEPO)
Velos Acquisition I Corp Equity (MBAV)
Republic Digital Acquisition Equity (RDAG)
Dynamix Corp Equity (DYNC)
Invest Acquisition Corp Equity (IVCBF)
Crane Harbor Acquisition Corp II Equity (CRAN)
Cal Redwood Acquisition Corp Equity (CRAQ)
Gores Holdings X Equity (GTEN)
KRAKacquisition Corp Equity (KRAQ)
Armada Acquisition Corp II Equity (XRPN)
Churchill Capital Corp IX Equity (CCIX)
Vendome Acquisition Corp I Equity (VNME)
BTC Development Corp Equity (BDCI)
Viking Acquisition Corp I Equity (VACI)

View all positions for Meteora Capital

Top funds holding Esperion Therapeutics

Meteora Capital

View all funds holding Esperion Therapeutics